Chen, Yao
Jiang, Yuanyuan
Yao, Xiaoxi
Li, Yimeng
Liu, Ruisi
Lv, Wencong
Zhong, Qinyi
Yan, Bin
Meng, Yongan
Luo, Jing
Wu, Mengbo
Guo, Jia
Funding for this research was provided by:
China Medical Board (21-424)
Article History
Received: 12 June 2022
Revised: 17 August 2022
Accepted: 20 September 2022
First Online: 7 October 2022
Declarations
:
: The study has been approved by the Institutional Review Board of the Second Xiangya Hospital, Central South University (No. LYF2022014). The trial will be conducted in accordance with the rules of Good Clinical Practice outlined in the Declaration of Helsinki. Potential participants will be all informed about the study in writing and orally. The information will describe the purpose and process of the study, the method used and publication plans. The information will also include confidentiality assurance, the principles for voluntary participation and included contact information to the researcher and organization behind the study. The written information will also include a form for obtaining a written informed consent. All the participants need sign and return the written informed consent prior to participation.
: Not applicable.
: The authors declare that they have no competing interests.
: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.